239 related articles for article (PubMed ID: 34417810)
1. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
Winkelman JW
Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
[TBL] [Abstract][Full Text] [Related]
2. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
3. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
Bayard S; Langenier MC; Dauvilliers Y
Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
[TBL] [Abstract][Full Text] [Related]
4. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Sun Y; van Valkenhoef G; Morel T
Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
[TBL] [Abstract][Full Text] [Related]
5. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
[TBL] [Abstract][Full Text] [Related]
6. Restless legs syndrome: differential diagnosis and management with pramipexole.
Brindani F; Vitetta F; Gemignani F
Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
[TBL] [Abstract][Full Text] [Related]
7. Restless legs syndrome: clinical presentation diagnosis and treatment.
Wijemanne S; Jankovic J
Sleep Med; 2015 Jun; 16(6):678-90. PubMed ID: 25979181
[TBL] [Abstract][Full Text] [Related]
8. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
Pourcher E; Rémillard S; Cohen H
J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
[TBL] [Abstract][Full Text] [Related]
9. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
Wang T; Ying M; Zhao R; Zhu D; Zhang L
Sleep Breath; 2022 Mar; 26(1):373-380. PubMed ID: 33864178
[TBL] [Abstract][Full Text] [Related]
10. Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome.
Kim J; Hartzema AG
Sleep Med; 2018 Apr; 44():45-52. PubMed ID: 29530369
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
Dostal M; Weber-Schoendorfer C; Sobesky J; Schaefer C
Eur J Neurol; 2013 Sep; 20(9):1241-6. PubMed ID: 23083216
[TBL] [Abstract][Full Text] [Related]
12. [Gambling addiction as a side effect of low dose pramipexole in the treatment of restless legs syndrome].
Lindström ES; Ibsen JD; Skovbølling SL
Ugeskr Laeger; 2022 Jun; 184(24):. PubMed ID: 35703072
[TBL] [Abstract][Full Text] [Related]
13. Treatment initiation and utilization patterns of pharmacotherapies for early-onset idiopathic restless legs syndrome.
Costales B; Vouri SM; Brown JD; Setlow B; Goodin AJ
Sleep Med; 2022 Aug; 96():70-78. PubMed ID: 35605349
[TBL] [Abstract][Full Text] [Related]
14. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).
Winkelman JW; Johnston L
Sleep Med; 2004 Jan; 5(1):9-14. PubMed ID: 14725821
[TBL] [Abstract][Full Text] [Related]
15. Newer dopamine agonists in the treatment of restless legs syndrome.
Weimerskirch PR; Ernst ME
Ann Pharmacother; 2001 May; 35(5):627-30. PubMed ID: 11346069
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
17. Treating Severe Refractory and Augmented Restless Legs Syndrome.
Winkelman JW
Chest; 2022 Sep; 162(3):693-700. PubMed ID: 35609673
[TBL] [Abstract][Full Text] [Related]
18. Pramipexole induced psychosis in a patient with restless legs syndrome.
Signorelli MS; Battaglia E; Costanzo MC; Cannavò D
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24049088
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with pramipexole in the treatment of restless legs syndrome.
Merlino G; Serafini A; Robiony F; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):225-35. PubMed ID: 18248314
[TBL] [Abstract][Full Text] [Related]
20. Pramipexole in the management of restless legs syndrome: an extended study.
Silber MH; Girish M; Izurieta R
Sleep; 2003 Nov; 26(7):819-21. PubMed ID: 14655914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]